[It impairs quality of life and work time. Migraine therapy should not be left to the patients!].
D000041:Absenteeism; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000191:economics; D002986:Clinical Trials as Topic; D004876:Ergot Alkaloids / Q000008:administration & dosage / Q000191:economics; D005858:Germany; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000191:economics*; D009784:Occupational Diseases / Q000188:drug therapy* / Q000191:economics*; D011788:Quality of Life; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage* / Q000191:economics; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage / Q000191:economics; D014363:Tryptamines
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004876:Ergot Alkaloids; D017366:Serotonin Receptor Agonists; D014230:Triazoles; D014363:Tryptamines; C093622:rizatriptan